Etiome

Cambridge, United States

Etiome, a company redefining how we detect and preempt disease progression.

$50.0M raised

Apr 2025

Series A

Top Investors

Flagship Pioneering

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Etiome raised?

Etiome has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in April 2025.

Who are Etiome's investors?

Etiome's investors include Flagship Pioneering.

Where is Etiome headquartered?

Etiome is headquartered in Cambridge, United States.

What does Etiome do?

Etiome, a company redefining how we detect and preempt disease progression.

What stage is Etiome at?

Etiome is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 24, 2025.

MLA

"Etiome — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/etiome. Accessed June 4, 2026.

APA

VCBacked. (2025). Etiome — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/etiome

Wikipedia (cite web)

{{cite web |title=Etiome — Funding & Investors |url=https://www.vcbacked.co/company/etiome |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 24, 2025.